Ranked #4,553 of 8,699 institutional investors
Elmind Capital, LP
New York, NY
$351M
US stock portfolio at live prices · today +$1.0M (+0.30%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $404M
- Change from Q2 2026
- +$5.8M (+1.46%)
- Positions
- 27 · 0 new, 5 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$37.4M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesVRDN 11.0%CLDX 8.84%LEGN 7.20%COGT 6.85%AMLX 6.68%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc. | 1,224,931 | $38.5M | 11.0% | Added +24% |
| CLDX Celldex Therapeutics, Inc. | 1,110,000 | $31.0M | 8.84% | Added +12% |
| LEGN Legend Biotech Corporation | 1,569,676 | $25.3M | 7.20% | Added +175% |
| COGT Cogent Biosciences, Inc. | 866,742 | $24.0M | 6.85% | Reduced −26% |
| AMLX Amylyx Pharmaceuticals, Inc. | 894,760 | $23.4M | 6.68% | Added +699% |
| RLAY Relay Therapeutics, Inc. | 1,465,279 | $23.3M | 6.64% | Unchanged |
| PCVX Vaxcyte, Inc. | 372,340 | $21.7M | 6.19% | Reduced −18% |
| TVTX Travere Therapeutics, Inc. | 322,600 | $15.6M | 4.44% | Added +10% |
| SNDX Syndax Pharmaceuticals, Inc. | 1,605,000 | $14.7M | 4.17% | Reduced −13% |
| VERA Vera Therapeutics, Inc. | 436,518 | $11.7M | 3.33% | Unchanged |
| BEAM Beam Therapeutics Inc. | 476,338 | $10.0M | 2.84% | Unchanged |
| CTMX CytomX Therapeutics, Inc. | 4,550,000 | $9.3M | 2.66% | Unchanged |
| CGEM Cullinan Therapeutics, Inc. | 962,792 | $8.7M | 2.49% | Added +40% |
| UTHR United Therapeutics Corporation | 15,000 | $8.4M | 2.39% | Unchanged |
| KRYS Krystal Biotech, Inc. | 22,000 | $6.9M | 1.98% | Unchanged |
| IMCR Immunocore Holdings plc | 256,143 | $6.8M | 1.94% | Added +216% |
| NRIX Nurix Therapeutics, Inc. | 460,000 | $6.3M | 1.78% | Unchanged |
| SMMT Summit Therapeutics Inc. | 493,820 | $5.2M | 1.49% | Unchanged |
| BCRX BioCryst Pharmaceuticals, Inc. | 520,000 | $3.8M | 1.08% | Unchanged |
| MBX MBX Biosciences, Inc. | 61,000 | $3.3M | 0.93% | Reduced −33% |
| ALMS Alumis Inc. | 749,560 | $3.2M | 0.92% | Added +477% |
| BMRN BioMarin Pharmaceutical Inc. | 47,000 | $2.9M | 0.82% | Unchanged |
| DBVT DBV Technologies S.A. | 265,000 | $2.5M | 0.71% | Unchanged |
| ALEC Alector, Inc. | 915,902 | $2.1M | 0.60% | Added +2% |
| STRO Sutro Biopharma, Inc. | 228,265 | $2.0M | 0.57% | Added +613% |
| SEPN Septerna, Inc. | 49,444 | $1.9M | 0.55% | Unchanged |
| DSGN Design Therapeutics, Inc. | 107,900 | $1.0M | 0.29% | Unchanged |